Company Reaffirms FY26 Revenue Outlook of $2.3B to $2.42B
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy CLVT?
Backs FY26 revenue view $2.3B-$2.42B, consensus $2.36B. Backs FY26 adjusted EBITDA view $980M-$1.04B. The company said, "We generated solid free cash flow of $79 million in the first quarter, reflecting strong Adjusted EBITDA performance and continued financial discipline. During the quarter, we used free cash flow and excess cash on hand to retire $143 million of debt, further strengthening our balance sheet. Based on our first-quarter performance and continued execution under the Value Creation Plan, we are reaffirming our full-year 2026 outlook, including expectations for margin expansion and approximately $400 million of free cash flow."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CLVT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CLVT
Wall Street analysts forecast CLVT stock price to rise
5 Analyst Rating
0 Buy
3 Hold
2 Sell
Moderate Sell
Current: 2.810
Low
3.00
Averages
3.90
High
5.00
Current: 2.810
Low
3.00
Averages
3.90
High
5.00
About CLVT
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Global Launch: Clarivate Plc announced the global launch of the Web of Science Research Intelligence platform on May 6, 2026, designed to support research institutions in funding, strategy, and impact decisions through AI-driven insights, marking a significant advancement in research intelligence.
- Collaborative Development: Developed in partnership with over 50 collaborators across 20 countries, the platform ensures alignment with real institutional needs, enhancing capabilities in securing funding and building collaboration networks for research institutions.
- Multidimensional Impact Framework: The platform helps institutions move beyond traditional productivity metrics by using multidimensional indicators to clearly articulate the societal impact of research, thereby enhancing the visibility of research contributions to policy and social outcomes.
- Data Integration Advantage: By integrating authoritative data from sources like the Web of Science Core Collection, the platform provides a reliable foundation for decision-making, ensuring transparency and traceability in research decisions, which boosts institutional confidence in high-stakes scenarios.
See More
- Global Launch: On May 6, 2026, Clarivate Plc announced the global launch of the Web of Science Research Intelligence platform, designed to support research institutions in funding, strategy, and impact decisions through AI-driven insights, marking a significant advancement in research intelligence.
- Collaborative Development: Developed in partnership with over 50 collaborators across 20 countries, the platform ensures its features align closely with actual research needs, thereby enhancing institutions' capabilities in securing funding and fostering collaboration, which strengthens their competitive position in academia.
- Data Integration: Web of Science Research Intelligence integrates data from publications, patents, funding, policy documents, and clinical trials into a single reliable foundation for decision-making, helping institutions effectively demonstrate the societal impact of their research and drive changes in policy and practice.
- AI-Driven Workflows: The platform's AI-guided workflows enable more users to contribute to research planning and strategy, not only increasing analysis speed but also enhancing decision confidence and clarity in communicating research value, further promoting the societal contributions of research.
See More
- Quarterly Revenue Performance: Clarivate reported first-quarter revenue just under $586 million, reflecting a slight 1% year-over-year decline, yet it surpassed analyst expectations of $569 million, demonstrating the company's competitive position in the market.
- Net Income Growth: The company's net income under GAAP rose nearly 25% to over $119 million ($0.18 per share), indicating a significant improvement in profitability and operational efficiency.
- Value Creation Plan: CEO Matti Shem Tov highlighted that the value creation plan launched in early 2025 is a key driver of performance improvement, aimed at simplifying the business model, enhancing commercial effectiveness, and accelerating innovation across the portfolio.
- Full-Year Guidance: Management reaffirmed its full-year revenue guidance of $2.30 billion to $2.42 billion and adjusted earnings per share guidance of $0.70 to $0.80, reflecting confidence in the company's growth trajectory amid ongoing strategic initiatives.
See More
- Consistent Performance Improvement: Clarivate reported Q1 2026 adjusted EPS of $0.18, surpassing analysts' expectations of $0.14, with revenues reaching $586 million, indicating ongoing progress in executing its Value Creation Plan, which is expected to drive full-year performance targets.
- Accelerated AI Innovation: CEO Matti Shem Tov emphasized the company's intensified investment in AI, particularly through new products like the 'Wave 1 AI Assistant', which is anticipated to significantly enhance customer efficiency, thereby strengthening the company's competitive position and profit margins.
- Expansion in China: Clarivate secured 15 new Web of Science contracts in China over the past year, demonstrating strong performance in this rapidly growing market, with potential for further increasing its market share in the Asia-Pacific region.
- Reaffirmed Financial Guidance: CFO Jonathan Collins reaffirmed the full-year financial guidance, including projected revenue of $2.36 billion and free cash flow of $400 million, while acknowledging potential divestiture risks, the company maintains an optimistic outlook for future growth.
See More
- Strong Financial Performance: Clarivate reported total revenues of $585.5 million for Q1, reflecting a 1.4% year-over-year decline, yet organic revenue growth of 0.6% indicates the company's execution strength and market adaptability under the Value Creation Plan.
- Robust Free Cash Flow: The company generated $78.9 million in free cash flow during the first quarter, reflecting strong adjusted EBITDA performance and financial discipline, which was further utilized to retire $143 million in debt, thereby strengthening the balance sheet.
- Significant Improvement in Net Loss: The net loss for Q1 improved to $40.2 million, or $0.06 per share, compared to a net loss of $103.9 million in the same period last year, marking a 61.3% improvement and showcasing positive progress in profitability.
- 2026 Outlook Reaffirmed: Clarivate reaffirmed its financial outlook for 2026, including expectations for approximately $400 million in free cash flow and adjusted EBITDA projected between $980 million and $1.04 billion, demonstrating confidence in future growth and a clear strategic direction.
See More
- Financial Recovery: Clarivate reported total revenues of $585.5 million for Q1, down 1.4% from $593.7 million last year, yet organic revenue growth of 0.6% indicates steady recovery under the Value Creation Plan.
- Strong Free Cash Flow: The company generated $79 million in free cash flow during Q1, a 28.5% decline from $110.3 million last year, but effectively reduced $143 million in debt through strong adjusted EBITDA performance and financial discipline, further strengthening its balance sheet.
- Significant Improvement in Net Loss: The net loss for Q1 was $40.2 million, or $0.06 per share, compared to a net loss of $103.9 million and $0.15 per share last year, showcasing a notable improvement in profitability.
- 2026 Outlook Reaffirmed: Clarivate reaffirmed its 2026 financial outlook, projecting revenues between $2.3 billion and $2.42 billion, with adjusted EBITDA expected between $980 million and $1.04 billion, reflecting the company's confidence in future growth.
See More











